NCT03844048
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Brief summary
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.
Interventional study
Status:
Enrolling by invitation
Conditions:
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Multiple Myeloma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Cancer
Enrollment:
550 patients
Phase:
- 1
- 2
- 3
- 4
Protocol ID:
M19-388
Allocation:
N/A
Intervention model:
Single Group Assignment
Masking:
None (Open Label)
Purpose:
Treatment
Would you like to know more about this trial?
|
Please note, participation in the clinical trial is open to patients with the disease or condition under investigation. |
Participant attributes:
Male and Female
Age:
N/A
Inclusion Criteria:
- Subject has been enrolled and dosed in an ongoing venetoclax study and continues to
tolerate and derive benefit from the study drug.
- Male subject agrees to refrain from sperm donation.
- Female subjects must not be pregnant or breastfeeding.
Exclusion Criteria:
- None.
All the cities where the clinical studies are located
Quebec City - G1J 1Z4
Quebec City - G1J 1Z4
